Systematic review of soy isoflavone supplements on osteoporosis in women

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 3, 2012, Pages 243-248

  Wei, Pan ^a   Liu, Ming ^a   Chen, Yan ^a   Chen, De Cai ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Bone mineral density; Serum bone alkaline phosphatase; Soy isoflavone; Systematic review; Urine deoxypyridinoline

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; ISOFLAVONE; PLACEBO;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; CLIMACTERIUM; DIET SUPPLEMENTATION; DISEASE CONTROL; DISEASE MARKER; FEMALE; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOYBEAN; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE LEVEL;

AMINO ACIDS; BONE DENSITY; BONE RESORPTION; DIETARY SUPPLEMENTS; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEAN PROTEINS;

EID: 84863037858     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60033-9     Document Type: Article

References (33)

1. Bone HG, Greenspan SL, McKeever C Alendronate and estrogen effects in postmenopausal women with low bone mineral density alendronate/estrogen study group. J Clin Endocrinol Metab 2000, 85(2):720-726.
2. Garn SM Bone loss and aging. Physiological and pathology of human aging 1975, Academic Press Inc, New York. R.R.M. Goldman (Ed.).
3. Gallagher JC The pathogenesis of osteoporosis. Bone Miner 1990, 9:215-227.
4. Stepan JJ, Pospichal J, Presl J, Pacovsky V Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 1987, 8:279-284.
5. Verhaeghe J, Van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, et al. Effects of recombinant human growth hormone and insulin-like growth factor-I, with and without 17-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. J Bone Miner Res 1996, 11:1723-1735.
6. Genant HK, Baylink DJ, Gallagher JC Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 1989, 161:1842-1846.
7. World Health Organization Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, Report of the WHO Study Group World Health Organ Tech Rep Ser. World Health Organization 1994, 843:1-129.
8. Henderson BE, Ross RK, Pike MC Hormonal chemoprevention of cancer in women. Science 1993, 259:633-638.
9. Judd HL, Meldrum DR, Deftos LJ, Henderson BE Estrogen replacement therapy: indications and complications. Ann Int Med 1983, 98:30-37.
10. Collaborative group on hormonal factors in breast cancer. Lancet 1997, 350:1047-1059. Collaborative Group on Hormonal Factors in Breast Cancer.
11. Brezinski A, Debi A Phytoestrogens: the " natural" selective estrogen receptor modulators. Eur J Obstet & Gynecol & Rep Bio 1999, 85:47-51.
12. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J The use of biochemical markers of bone turnover in osteoporosis Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2000, 11(Suppl):S2-17.
13. Adlercreutz H, Mazur W Phyto-oestrogens and Western diseases. Ann Med 1997, 29:95-120.
14. Somekawa Y, Chiguchi M, Ishibashi T, Aso T Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001, 97(1):109-115.
15. Zhang X, Shu XO, Li H, Yang G, Li Q, Gao YT, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005, 165(16):1890-1895.
16. Messina MJ Soy foods and soybean isoflavones and menopausal health. Nutr Clin Care 2002, 5(6):272-282.
17. Wong WW, Lewis RD, Steinberg FM, Murray MJ, Cramer MA, Amato P, et al. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr 2009, 90:234-242.
18. Kenny AM, Mangano KM, Abourizk RH, Bruno RS, Anamani DE, Kleppinger A Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial. Am J Clin Nutr 2009, 90:234-242.
19. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 2008, 87:761-770.
20. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008, 93:4787-4796.
21. Shao XJ, Ye ZQ, Luo CX, Cai DZ Effect of soy isoflavones on osteoporosis in postmenopausal women. Academic J Sun Yat-Sen Univ 2007, 28:241-242.
22. Wu CF, Wu DC, Hsu HK, Kao EL, Lee JM, Lin CC, et al. Relationship between genetic polymorphisms of alcohol and aldehyde dehydrogenases and esophageal squamous cell carcinoma risk in males. World J Gastroenterol 2005, 11:5103-5108.
23. Ye YB, Tang XY, Verbruggen MA, Su YX Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: a single-blind randomized, placebocontrolled trial. Eur J Nutr 2006, 45:327-334.
24. Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, Wong E Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004, 79:318-325.
25. Harkness LS, Fiedler K, Sehgal AR, Oravec D, Lerner E Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt) 2004, 13:1000-1007.
26. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004, 292:65-74.
27. Nikander E, Metsä-Heikkilä M, Ylikorkala O, Tiitinen A Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J Clin Endocrinol Metab 2004, 89(3):1207-1212.
28. Dalais FS, Ebeling PR, Kotsopoulos D, McGrath BP, Teede HJ The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) 2003, 58:704-709.
29. Uesugi S, Watanabe S, Ishiwata N, Uehara M, Ouchi K Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors 2002, 22:221-228.
30. Yamori Y, Moriguchi EH, Teramoto T, Miura A, Fukui Y, Honda KI Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J Am Coll Nutr 2002, 21:560-563.
31. Nielsen TF, Ravn P, Bagger YZ, Warming L, Christiansen C Used estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int 2004, 15:168-174.
32. Seeman E Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr Osteoporos Rep 2004, 2:90-96.
33. Ma DF, Qin LQ, Wang PY, Katoh R Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 2008, 27(1):57-64.